Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Ariad's private placement nets $23mm

Executive Summary

Cancer company Ariad Pharmaceuticals netted $23mm through the placement of 14mm common shares at $1.69 each (a 29% discount) to new and returning institutional investors. Buyers also received three-year warrants to purchase 10.8mm shares at $2.15 each. Lazard was the placement agent.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Investment in Public Equity
    • Private Placement

Related Companies